Author

Bob M Moore II

Univeristy of Tennessee Health Science Center - Cited by 2,086 - Medicinal Chemistry

Biography

Dr. Bob M Moore II is currently working in Department of Pharmaceutical Sciences at The University of Tennessee Health Science Center USA.Department of Pharmaceutical Sciences, The University of Tennessee Health Science Center, USA
Title
Cited by
Year
Motor, visual and emotional deficits in mice after closed-head mild traumatic brain injury are alleviated by the novel CB2 inverse agonist SMM-189
A Reiner, SA Heldt, CS Presley, NH Guley, AJ Elberger, Y Deng, ...Int. J. Mol. Sci. 16, 758-787, 2015201
77
2015
Mild traumatic brain injury produces neuron loss that can be rescued by modulating microglial activation using a CB2 receptor inverse agonist
W Bu, H Ren, Y Deng, N Del Mar, NM Guley, BM Moore, MG Honig, ...Frontiers in neuroscience 10, 449, 2016201
60
2016
Pre-clinical Evaluation of SMM-189, a Cannabinoid Receptor 2 Specific Inverse Agonist
MBMII Presley C, Abidi A, Suryawanshi S, Mustafa S, Meibohm BPharmacol Res Perspect., e00159, 2015201
40
2015
Endocannabinoid crosstalk between placenta and maternal fat in a baboon model (Papio spp.) of obesity
B Brocato, AA Zoerner, Z Janjetovic, C Skobowiat, S Gupta, BM Moore II, ...Placenta 34 (11), 983-989, 2013201
36
2013
Anti-inflammatory activity of cannabinoid receptor 2 ligands in primary hPDL fibroblasts
AH Abidi, CS Presley, M Dabbous, DA Tipton, SM Mustafa, BM Moore IIArchives of Oral Biology 87, 79-85, 2018201
34
2018
Amelioration of visual deficits and visual system pathology after mild TBI with the cannabinoid type-2 receptor inverse agonist SMM-189
NM Guley, NA Del Mar, T Ragsdale, C Li, AM Perry, BM Moore, MG Honig, ...Experimental eye research 182, 109-124, 2019201
33
2019
Selective cannabinoid 2 receptor stimulation reduces tubular epithelial cell damage after renal ischemia-reperfusion injury
JD Pressly, SM Mustafa, AH Abidi, S Alghamdi, P Pandey, KK Roy, ...Journal of Pharmacology and Experimental Therapeutics 364 (2), 287-299, 2018201
31
2018
Inverse agonism of cannabinoid receptor type 2 confers anti-inflammatory and neuroprotective effects following status epileptics
Y Yu, L Li, DT Nguyen, SM Mustafa, BM Moore, J JiangMolecular neurobiology 57, 2830-2845, 2020202
27
2020
Amelioration of visual deficits and visual system pathology after mild TBI via the cannabinoid Type-2 receptor inverse agonism of raloxifene
MG Honig, NA Del Mar, DL Henderson, TD Ragsdale, JB Doty, JH Driver, ...Experimental neurology 322, 113063, 2019201
26
2019
Abnormalities in dynamic brain activity caused by mild traumatic brain injury are partially rescued by the cannabinoid type-2 receptor inverse agonist SMM-189
Abnormalities in dynamic brain activity caused by mild traumatic brain injury are partially rescued by the cannabinoid type-2 receptor inverse agonist SMM-9Y Liu, SS McAfee, NM Guley, N Del Mar, W Bu, SA Heldt, MG Honig, ...eneuro 4 (4), 2017201
18
2017
Cannabinoid type‐2 receptor agonist, inverse agonist, and anandamide regulation of inflammatory responses in IL‐1β stimulated primary human periodontal ligament fibroblasts
AH Abidi, SS Alghamdi, MK Dabbous, DA Tipton, SM Mustafa, BM MooreJournal of Periodontal Research 55 (5), 762-783, 2020202
16
2020
Activation of the cannabinoid receptor 2 increases renal perfusion
JD Pressly, H Soni, S Jiang, J Wei, R Liu, BM Moore, A Adebiyi, F ParkPhysiological genomics, 2019201
15
2019
Synthesis and biological evaluation of (3′, 5′-dichloro-2, 6-dihydroxy-biphenyl-4-yl)-aryl/alkyl-methanone selective CB2 inverse agonist
CS Presley, SM Mustafa, AH Abidi, BM Moore IIBioorganic & medicinal chemistry 23 (17), 5390-5401, 202
15
2015
Sex and strain variation in initial sensitivity and rapid tolerance to Δ9–tetrahydrocannabinol
C Parks, BC Jones, BM Moore, MK MulliganCannabis and Cannabinoid Research 5 (3), 231-245, 2020202
13
2020
Comparison and functional genetic analysis of striatal protein expression among diverse inbred mouse strains
C Parks, F Giorgianni, BC Jones, S Beranova-Giorgianni, BM Moore II, ...Frontiers in molecular neuroscience 12, 128, 2019201
11
2019
Cannabinoid Receptor 1 Ligands Revisited: Pharmacologic Assessment in the ACTOne System
II C. S. Presley, A. Abidi, B. M. MooreAnal. Biochem. 498, 8-28, 2016201
10
2016
Synthesis and biological evaluation of a ring analogs of the selective CB2 inverse agonist SMM-189
Synthesis and biological evaluation of a ring analogs of the selective CB2 inverse agonist SMM-19SS Alghamdi, SM Mustafa, BM Moore IIBioorganic & Medicinal Chemistry 33, 116035, 2021202
8
2021
Raloxifene modulates microglia and rescues visual deficits and pathology after impact traumatic brain injury
MG Honig, NA Del Mar, DL Henderson, D O’Neal, JB Doty, R Cox, C Li, ...Frontiers in Neuroscience 15, 701317, 2021202
8
2021
Cannabinoid type 2 receptor activation reduces the progression of kidney fibrosis using a mouse model of unilateral ureteral obstruction
ML Swanson, KR Regner, BM Moore, F ParkCannabis and cannabinoid research (6), 90-803, 2022202
7
2022
Benzofuran cannabinoid compounds and related methods of use
IIBM Moore, S Gurley, S MustafaUS Patent 8,47,309, 2013201
6
2013

Referred From: https://scholar.google.com/citations?user=gWHJVX0AAAAJ&hl=en

Cited by
Citations 2086
h-index 26
i10-index 47
Recommended Journals
Open Access Journals